Breast Cancer Blood Test to Guide Treatment Choices
Part of Cancer, Skin clinical trials.
This study examines tiny particles in your blood from breast cancer cells to better predict which treatments will work best for you. Researchers will collect blood samples and a small tissue sample to understand your cancer's characteristics and help doctors choose more effective therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–75 years old
- Advanced breast cancer that cannot be surgically removed or has spread to other parts of the body
- Willing to have a needle biopsy (small tissue sample) taken from your cancer before starting new treatment
- At least one measurable tumor or bone-only metastases (cancer in bones)
- Adequate blood cell counts, liver, kidney, and heart function on recent lab tests
- Recovered from side effects of any previous cancer treatments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.
This study looks at tiny particles in your blood and tumor to see if they can predict how well your chemotherapy will work for breast cancer. The goal is to help guide treatment based on your individual cancer.
This study looks at blood and tissue samples from people newly diagnosed with breast cancer to better understand the disease and possibly find better ways to treat it. It is for people who have not yet started treatment, so it may be an opportunity to contribute to research early in your journey.
This study is testing a new blood test that looks for cancer cells in your blood and checks if your tumor has a specific feature linked to DNA repair. The goal is to see if this blood test can help guide whether PARP inhibitor medicines—which target cancers with this feature—might work for you.
This study is testing a way to use a simple blood test during chemotherapy to see how well the treatment is working in certain breast cancers. The goal is to make sure you get the best treatment for your tumor type.
This study looks at tiny particles released by cells (called extracellular vesicles) in people with breast cancer. It may help researchers better understand breast cancer and how it behaves, which could improve future testing or treatments.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.